Return to news index

FEI Tribunal issues Final Decision in human anti-doping case

The FEI Tribunal has issued its Final Decision in a human anti-doping case involving an adverse analytical finding for the prohibited substance Benzoylecgonine, a metabolite of cocaine, and Amfetamine. Both are non-specified substances that are prohibited in competition under the 2018 WADA Prohibited List.

Samples taken from the athlete Jan-Philipp Weichert (FEI ID 10072662/GER) on 10 June 2018 during the German National Championships, CSI2* in Balve (GER) returned positive for the two substances.

The FEI Tribunal approved the agreement between the FEI and the athlete on 13 July 2020.

The Athlete admitted the violation and the FEI Tribunal accepted that the violation was not intentional, since the substances were consumed in a context unrelated to sport, the standard four-year ineligibility period was reduced to two years. The athlete has already served the ineligibility period, which started on 2 July 2018 and ended on 1 July 2020.

All results recorded by the athlete from the date of the event were disqualified. The athlete was also ordered to pay a fine of CHF 1,500. Each party will pay their own legal costs.

The Final Tribunal Decision can be found here.

The parties can appeal to the Court of Arbitration for Sport (CAS) within 21 days of receipt of the Decision.

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now

×